Will Surgery Partners, Inc. (SGRY) Go Down Anytime Soon?

December 7, 2017 - By Winifred Garcia

The stock of Surgery Partners, Inc. (NASDAQ:SGRY) is a huge mover today! The stock increased 5.99% or $0.5 during the last trading session, reaching $8.85. About 418,984 shares traded. Surgery Partners, Inc. (NASDAQ:SGRY) has risen 53.68% since December 7, 2016 and is uptrending. It has outperformed by 36.98% the S&P500.
The move comes after 8 months positive chart setup for the $431.61M company. It was reported on Dec, 7 by Barchart.com. We have $9.65 PT which if reached, will make NASDAQ:SGRY worth $38.84 million more.

Analysts await Surgery Partners, Inc. (NASDAQ:SGRY) to report earnings on March, 8. They expect $0.13 earnings per share, down 31.58 % or $0.06 from last year’s $0.19 per share. SGRY’s profit will be $6.34M for 17.02 P/E if the $0.13 EPS becomes a reality. After $-0.04 actual earnings per share reported by Surgery Partners, Inc. for the previous quarter, Wall Street now forecasts -425.00 % EPS growth.

Surgery Partners, Inc. (NASDAQ:SGRY) Ratings Coverage

Among 10 analysts covering Surgery Partners (NASDAQ:SGRY), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Surgery Partners had 29 analyst reports since October 26, 2015 according to SRatingsIntel. The rating was maintained by KeyBanc Capital Markets on Tuesday, October 31 with “Hold”. The rating was maintained by RBC Capital Markets on Thursday, August 10 with “Buy”. The firm has “Sell” rating given on Wednesday, August 9 by Stifel Nicolaus. The stock of Surgery Partners, Inc. (NASDAQ:SGRY) earned “Buy” rating by Bank of America on Monday, October 9. Citigroup maintained the shares of SGRY in report on Friday, August 11 with “Buy” rating. The stock of Surgery Partners, Inc. (NASDAQ:SGRY) has “Buy” rating given on Monday, October 26 by Jefferies. Citigroup maintained Surgery Partners, Inc. (NASDAQ:SGRY) on Monday, March 14 with “Buy” rating. The firm has “Buy” rating given on Tuesday, October 27 by Stifel Nicolaus. The rating was maintained by KeyBanc Capital Markets with “Hold” on Wednesday, September 20. Stifel Nicolaus maintained Surgery Partners, Inc. (NASDAQ:SGRY) on Wednesday, June 21 with “Hold” rating.

More notable recent Surgery Partners, Inc. (NASDAQ:SGRY) news were published by: Nasdaq.com which released: “Bain Capital Investors Llc Buys Surgery Partners Inc, Sells Acadia Healthcare …” on November 20, 2017, also Globenewswire.com with their article: “Surgery Partners, Inc. Announces Third Quarter 2017 Results” published on November 08, 2017, Globenewswire.com published: “Surgery Partners, Inc. Announces Third Quarter 2017 Earnings Release Date and …” on November 01, 2017. More interesting news about Surgery Partners, Inc. (NASDAQ:SGRY) were released by: Forbes.com and their article: “Surgery Partners Stock Plummets After Q2 Results Hint At Integration Challenges” published on August 10, 2017 as well as Prnewswire.com‘s news article titled: “Scott+Scott, Attorneys at Law, LLP Announces Investigation into Surgery …” with publication date: December 07, 2017.

Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company has market cap of $431.61 million. The firm operates through three divisions: Surgical Facility Services, Ancillary Services, and Optical Services. It currently has negative earnings. The Company’s surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastrointestinal, general surgery, ophthalmology, orthopedics, and pain management.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.